These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 2194093

  • 1. Demonstration of RNA N-glycosidase activity of a Vero toxin (VT2 variant) produced by Escherichia coli O91:H21 from a patient with the hemolytic uremic syndrome.
    Furutani M, Ito K, Oku Y, Takeda Y, Igarashi K.
    Microbiol Immunol; 1990; 34(4):387-92. PubMed ID: 2194093
    [Abstract] [Full Text] [Related]

  • 2. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins.
    Endo Y, Tsurugi K, Yutsudo T, Takeda Y, Ogasawara T, Igarashi K.
    Eur J Biochem; 1988 Jan 15; 171(1-2):45-50. PubMed ID: 3276522
    [Abstract] [Full Text] [Related]

  • 3. Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28 S RNA when microinjected into Xenopus oocytes.
    Saxena SK, O'Brien AD, Ackerman EJ.
    J Biol Chem; 1989 Jan 05; 264(1):596-601. PubMed ID: 2642481
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of protein synthesis by a Vero toxin (VT2 or Shiga-like toxin II) produced by Escherichia coli O157:H7 at the level of elongation factor 1-dependent aminoacyl-tRNA binding to ribosomes.
    Ogasawara T, Ito K, Igarashi K, Yutsudo T, Nakabayashi N, Takeda Y.
    Microb Pathog; 1988 Feb 05; 4(2):127-35. PubMed ID: 3059137
    [Abstract] [Full Text] [Related]

  • 5. Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with the hemolytic uremic syndrome.
    Ito H, Terai A, Kurazono H, Takeda Y, Nishibuchi M.
    Microb Pathog; 1990 Jan 05; 8(1):47-60. PubMed ID: 2185397
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the modes of action of a Vero toxin (a Shiga-like toxin) from Escherichia coli, of ricin, and of alpha-sarcin.
    Furutani M, Kashiwagi K, Ito K, Endo Y, Igarashi K.
    Arch Biochem Biophys; 1992 Feb 14; 293(1):140-6. PubMed ID: 1731630
    [Abstract] [Full Text] [Related]

  • 7. The mechanism of action of the cytotoxic lectin from Phoradendron californicum: the RNA N-glycosidase activity of the protein.
    Endo Y, Oka T, Tsurugi K, Franz H.
    FEBS Lett; 1989 May 08; 248(1-2):115-8. PubMed ID: 2721668
    [Abstract] [Full Text] [Related]

  • 8. The mechanism of action of barley toxin: a type 1 ribosome-inactivating protein with RNA N-glycosidase activity.
    Endo Y, Tsurugi K, Ebert RF.
    Biochim Biophys Acta; 1988 May 18; 954(2):224-6. PubMed ID: 3365439
    [Abstract] [Full Text] [Related]

  • 9. Patients with haemolytic uraemic syndrome caused by Escherichia coli O157: absence of antibodies to Vero cytotoxin 1 (VT1) or VT2.
    Chart H, Law D, Rowe B, Acheson DW.
    J Clin Pathol; 1993 Nov 18; 46(11):1053-4. PubMed ID: 8254096
    [Abstract] [Full Text] [Related]

  • 10. Hemolytic uremic syndrome due to shiga-like toxin producing Escherichia coli 048:H21 in South Australia.
    Goldwater PN, Bettelheim KA.
    Emerg Infect Dis; 1995 Nov 18; 1(4):132-3. PubMed ID: 8903183
    [No Abstract] [Full Text] [Related]

  • 11. The site of action of the A-chain of mistletoe lectin I on eukaryotic ribosomes. The RNA N-glycosidase activity of the protein.
    Endo Y, Tsurugi K, Franz H.
    FEBS Lett; 1988 Apr 25; 231(2):378-80. PubMed ID: 3360143
    [Abstract] [Full Text] [Related]

  • 12. Analysis of the antigenic difference between Vero toxin 2 (VT2) and VT2 variant (VT2vh) of Verotoxin-producing Escherichia coli by a site-directed mutagenesis.
    Ito H, Nishibuchi M, Takeda Y.
    FEMS Microbiol Lett; 1991 Mar 15; 63(1):27-30. PubMed ID: 2044938
    [Abstract] [Full Text] [Related]

  • 13. Importance of arginine at position 170 of the A subunit of Vero toxin 1 produced by enterohemorrhagic Escherichia coli for toxin activity.
    Yamasaki S, Furutani M, Ito K, Igarashi K, Nishibuchi M, Takeda Y.
    Microb Pathog; 1991 Jul 15; 11(1):1-9. PubMed ID: 1795624
    [Abstract] [Full Text] [Related]

  • 14. The RNA N-glycosidase activity of ricin A-chain. The characteristics of the enzymatic activity of ricin A-chain with ribosomes and with rRNA.
    Endo Y, Tsurugi K.
    J Biol Chem; 1988 Jun 25; 263(18):8735-9. PubMed ID: 3288622
    [Abstract] [Full Text] [Related]

  • 15. Uncompetitive inhibition by adenine of the RNA-N-glycosidase activity of ribosome-inactivating proteins.
    Pallanca A, Mazzaracchio R, Brigotti M, Carnicelli D, Alvergna P, Sperti S, Montanaro L.
    Biochim Biophys Acta; 1998 May 19; 1384(2):277-84. PubMed ID: 9659388
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2).
    Oku Y, Yutsudo T, Hirayama T, O'Brien AD, Takeda Y.
    Microb Pathog; 1989 Feb 19; 6(2):113-22. PubMed ID: 2654533
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.